SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $14,337,000 | +89.0% | 84,100 | +55.7% | 1.12% | +80.8% |
| Q3 2020 | $7,584,000 | -21.2% | 54,000 | -10.0% | 0.62% | -50.0% |
| Q2 2020 | $9,620,000 | +91.3% | 60,000 | +16.7% | 1.24% | +28.9% |
| Q1 2020 | $5,028,000 | -52.5% | 51,400 | -37.3% | 0.96% | -52.8% |
| Q4 2019 | $10,581,000 | -24.3% | 82,000 | -10.9% | 2.04% | -25.6% |
| Q2 2019 | $13,979,000 | +30.3% | 92,000 | +2.2% | 2.75% | +26.0% |
| Q1 2019 | $10,727,000 | +25.9% | 90,000 | +15.2% | 2.18% | -13.1% |
| Q4 2018 | $8,523,000 | -33.2% | 78,100 | -1.1% | 2.51% | +9.7% |
| Q3 2018 | $12,759,000 | +34.1% | 79,000 | +9.7% | 2.29% | +25.0% |
| Q2 2018 | $9,517,000 | +32.4% | 72,000 | -25.8% | 1.83% | -25.7% |
| Q1 2018 | $7,187,000 | +40.4% | 97,000 | +5.4% | 2.46% | +24.4% |
| Q4 2017 | $5,119,000 | +12.9% | 92,000 | -8.0% | 1.98% | +51.9% |
| Q3 2017 | $4,536,000 | – | 100,000 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |